Risperidone
- TRADE NAMES: Risperdal (Ortho-McNeil, Janssen); Risperdal Consta (Ortho-McNeil, Janssen)
- INDICATIONS: Schizophrenia, bipolar mania, irritability associated with autistic disorder
- CLASS: Antipsychotic, Mood stabilizer
- HALF-LIFE: 3–30 hours
ACE inhibitors, Alcohol, Alpha blockers, Amantadine, Angiotensin II receptor antagonists, Anxiolytics and hypnotics, Apomorphine, Artemether/Lumefantrine, Barbiturates, Bromocriptine, Cabergoline, Calcium channel blockers, Carbamazepine, Cimetidine, Citalopram, Clozapine, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Ethosuximide, Fluoxetine, General anesthetics, Histamine, Levodopa, Memantine, Methyldopa, Metoclopramide, Opioid analgesics, Oxcarbazepine, Paliperidone, Paroxetine Hydrochloride, Pergolide, Phenytoin, Pramipexole, Primidone, Ranitidine, Ritonavir, Ropinirole, Rotigotine, Sodium Oxybate, Sympathomimetics, Tetrabenazine, Tramadol, Tricyclics, Valproic Acid, Viloxazine
PREGNANCY CATEGORY: C
Safety and effectiveness have not been established for pediatric patients with schizophrenia <13 years of age, for bipolar mania <10 years of age, and for autistic disorder <5 years of age.
[C] = in children.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 04/12/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
